Showing results (101-110 of 315) with videos related to
Sort By:
Pageof 32
Cancer Research|November 15, 1988
Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentrationW T Bellamy, R T Dorr, W S Dalton, et al.American Journal of Clinical Oncology|June 1, 1983
m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group studyR D Hilgers, S S Legha, F J Panettiere, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Phase I trial of retinol in cancer patientsG E Goodman, D S Alberts, D L Earnst, et al.Cancer Research|April 1, 1988
Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantroneW S Dalton, A E Cress, D S Alberts, et al.Cancer Treatment Reports|February 1, 1984
Reduced bisantrene-induced cytotoxicity and protein-associated DNA strand breaks under hypoxic conditionC U Ludwig, G T Bowden, R A Roberts, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell linesM J Xu, D S Alberts, R Liu, et al.Cancer Treatment Reports|November 1, 1985
Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group StudyD S Alberts, S P Balcerzak, J D Bonnet, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The disposition of intraperitoneal bleomycin, melphalan, and vinblastine in cancer patientsD S Alberts, H S Chen, S Y Chang, et al.Journal of Medicinal Chemistry|March 19, 1993
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agentS M Sami, R T Dorr, D S Alberts, et al.Journal of Leukocyte Biology|May 1, 1986
Cellular immune functions of adults treated with a daily, long-term, low dose of 13-cis retinoic acidR R Watson, J C Jackson, D S Alberts, et al.Pageof 32